DrugDashboards

Market view

staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans

2 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • StaphylococcinumJul 29, 2026
    Mfr exited
    Boiron · staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans
  • StaphylococcinumJul 29, 2026
    Mfr exited
    Boiron · staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans
  • StaphylococcinumJul 22, 2026
    Mfr entered
    Boiron · staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans
  • StaphylococcinumJul 22, 2026
    Mfr entered
    Boiron · staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans

Common questions

Is Staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans in shortage right now?
No. FDA does not currently list Staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans?
1 company has marketed Staphylococcus epidermidis, staphylococcus haemolyticus, staphylococcus simulans in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.